JPRN-UMIN000026192已完成未知
Examination about the confirmation of the efficacy at change from brand-name sustained-release oxycodone to generic sustained-release oxycodone. - Examination about the confirmation of the efficacy at change from brand-name sustained-release oxycodone to generic sustained-release oxycodone.
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable(—)
- 性别
- All
入选标准
- 未提供
排除标准
- •Change in basal dose within two weeks before the entry, Increases or decreases in frequency of the rescue dose within two weeks before the entry, Judged inappropriate by the doctor
研究者
相似试验
已完成
不适用
Test for confirming the efficacy of an intervention program using videos for enhancing mother-infant bondingMother-to-infant Bonding DisorderJPRN-UMIN000044812Mejiro University640
已完成
Unknown
Confirmatory study of the efficacy and effectiveness of egg consumption on cognitive function improvement in Japanese adults - A placebo-controlled, double-blind, randomized, comparative trial-.AdultsJPRN-UMIN000050219IMEQRD Co., Ltd100
进行中(未招募)
1 期
A Proof of Biological Efficacy Study Assessing the Potential of Piboserod a Specific 5-HT4 Antagonist for the Treatment of Symptomatic Congestive Heart Failure in stable outpatients NYHA class II-III on top of Usual Evidence Based Pharmacological treatmentMedDRA version: 4.0 Level: LLT Classification code 10010684Congestive heart failureEUCTR2005-004487-22-GBBio-Medisinsk Innovasjon AS156
进行中(未招募)
不适用
A Proof of Biological Efficacy Study Assessing the Potential of Piboserod a Specific 5-HT4 Antagonist for the Treatment of Symptomatic Congestive Heart Failure in stable outpatients NYHA class II-III on top of Usual Evidence Based Pharmacological treatmentMedDRA version: 4.0Level: LLTClassification code 10010684Congestive heart failureEUCTR2005-004487-22-DKBio-Medisinsk Innovasjon AS156
招募中
3 期
A confirmatory clinical study of ISN001 in patients with epidermolysis bullosaJPRN-jRCT2033210128Ishiko Akira8
